These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 21778928)

  • 1. The role of quantitative NPTX2 hypermethylation as a novel serum diagnostic marker in pancreatic cancer.
    Park JK; Ryu JK; Yoon WJ; Lee SH; Lee GY; Jeong KS; Kim YT; Yoon YB
    Pancreas; 2012 Jan; 41(1):95-101. PubMed ID: 21778928
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative analysis of NPTX2 hypermethylation is a promising molecular diagnostic marker for pancreatic cancer.
    Park JK; Ryu JK; Lee KH; Lee JK; Yoon WJ; Lee SH; Yoo JW; Woo SM; Lee GY; Lee CH; Kim YT; Yoon YB
    Pancreas; 2007 Oct; 35(3):e9-15. PubMed ID: 17895837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NPTX2 hypermethylation in pure pancreatic juice predicts pancreatic neoplasms.
    Yao F; Sun M; Dong M; Jing F; Chen B; Xu H; Wang S
    Am J Med Sci; 2013 Sep; 346(3):175-80. PubMed ID: 23360791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preliminary study analyzing the methylated genes in the plasma of patients with pancreatic cancer.
    Park JW; Baek IH; Kim YT
    Scand J Surg; 2012; 101(1):38-44. PubMed ID: 22414467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical significance of promoter methylation status of tumor suppressor genes in circulating DNA of pancreatic cancer patients.
    Singh N; Rashid S; Rashid S; Dash NR; Gupta S; Saraya A
    J Cancer Res Clin Oncol; 2020 Apr; 146(4):897-907. PubMed ID: 32146565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA methylation alterations in the pancreatic juice of patients with suspected pancreatic disease.
    Matsubayashi H; Canto M; Sato N; Klein A; Abe T; Yamashita K; Yeo CJ; Kalloo A; Hruban R; Goggins M
    Cancer Res; 2006 Jan; 66(2):1208-17. PubMed ID: 16424060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CpG island hypermethylation of cell-free circulating serum DNA in patients with testicular cancer.
    Ellinger J; Albers P; Perabo FG; Müller SC; von Ruecker A; Bastian PJ
    J Urol; 2009 Jul; 182(1):324-9. PubMed ID: 19447423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential methylation of cell-free circulating DNA among patients with pancreatic cancer versus chronic pancreatitis.
    Liggett T; Melnikov A; Yi QL; Replogle C; Brand R; Kaul K; Talamonti M; Abrams RA; Levenson V
    Cancer; 2010 Apr; 116(7):1674-80. PubMed ID: 20143430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CEACAM1, a novel serum biomarker for pancreatic cancer.
    Simeone DM; Ji B; Banerjee M; Arumugam T; Li D; Anderson MA; Bamberger AM; Greenson J; Brand RE; Ramachandran V; Logsdon CD
    Pancreas; 2007 May; 34(4):436-43. PubMed ID: 17446843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum heat shock protein 27 is increased in chronic pancreatitis and pancreatic carcinoma.
    Liao WC; Wu MS; Wang HP; Tien YW; Lin JT
    Pancreas; 2009 May; 38(4):422-6. PubMed ID: 19214136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low correspondence between K-ras mutations in pancreatic cancer tissue and detection of K-ras mutations in circulating DNA.
    Marchese R; Muleti A; Pasqualetti P; Bucci B; Stigliano A; Brunetti E; De Angelis M; Mazzoni G; Tocchi A; Brozzetti S
    Pancreas; 2006 Mar; 32(2):171-7. PubMed ID: 16552337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CpG island hypermethylation in cell-free serum DNA identifies patients with localized prostate cancer.
    Ellinger J; Haan K; Heukamp LC; Kahl P; Büttner R; Müller SC; von Ruecker A; Bastian PJ
    Prostate; 2008 Jan; 68(1):42-9. PubMed ID: 18004747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel serum metabolomics-based diagnostic approach to pancreatic cancer.
    Kobayashi T; Nishiumi S; Ikeda A; Yoshie T; Sakai A; Matsubara A; Izumi Y; Tsumura H; Tsuda M; Nishisaki H; Hayashi N; Kawano S; Fujiwara Y; Minami H; Takenawa T; Azuma T; Yoshida M
    Cancer Epidemiol Biomarkers Prev; 2013 Apr; 22(4):571-9. PubMed ID: 23542803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA methylation alterations in endoscopic retrograde cholangiopancreatography brush samples of patients with suspected pancreaticobiliary disease.
    Parsi MA; Li A; Li CP; Goggins M
    Clin Gastroenterol Hepatol; 2008 Nov; 6(11):1270-8. PubMed ID: 18995218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Detection of free tumor-related DNA in the serum of breast cancer patients].
    Zhang JJ; Ouyang T; Wan WH; Deng GR
    Zhonghua Zhong Liu Za Zhi; 2007 Aug; 29(8):609-13. PubMed ID: 18210882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Age- and disease-related methylation of multiple genes in nonneoplastic duodenum and in duodenal juice.
    Matsubayashi H; Sato N; Brune K; Blackford AL; Hruban RH; Canto M; Yeo CJ; Goggins M
    Clin Cancer Res; 2005 Jan; 11(2 Pt 1):573-83. PubMed ID: 15701843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuronal pentraxin II (NPTX2) is frequently down-regulated by promoter hypermethylation in pancreatic cancers.
    Zhang L; Gao J; Li Z; Gong Y
    Dig Dis Sci; 2012 Oct; 57(10):2608-14. PubMed ID: 22806544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aberrant methylation of secreted apoptosis-related protein 2 (SARP2) in pure pancreatic juice in diagnosis of pancreatic neoplasms.
    Watanabe H; Okada G; Ohtsubo K; Yao F; Jiang PH; Mouri H; Wakabayashi T; Sawabu N
    Pancreas; 2006 May; 32(4):382-9. PubMed ID: 16670620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor marker M2-pyruvate-kinase in differential diagnosis of chronic pancreatitis and pancreatic cancer.
    Novotný I; Dítĕ P; Dastych M; Záková A; Trna J; Novotná H; Nechutová H
    Hepatogastroenterology; 2008; 55(85):1475-7. PubMed ID: 18795715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative detection of promoter hypermethylation of multiple genes in the tumor, urine, and serum DNA of patients with renal cancer.
    Hoque MO; Begum S; Topaloglu O; Jeronimo C; Mambo E; Westra WH; Califano JA; Sidransky D
    Cancer Res; 2004 Aug; 64(15):5511-7. PubMed ID: 15289362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.